Oxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania
摘要:
Compounds belonging to three different classes of fused heterocyclic systems, structurally related to Calcium-channel blockers of the 1,4-dihydropyridine family, were evaluated in their ability to overcome leishmanial resistance to common drugs in a MDR Leishmania tropica strain. Compounds with the skeletal basis of oxazolo[3,2-a]pyridine displayed significant reversion of resistance to daunomycin and miltefosine, with reversion indexes up to 6.7-fold and 8.7-fold, respectively. Most interestingly, the enantiopure compound 20S attained to revert the resistance to both drugs and fairly more significantly than its enantiomer 20R. (C) 2012 Elsevier Ltd. All rights reserved.
1,4-dihydropyridines, N-substituted bicyclic 4-hydropyridines, and
申请人:Apotex, Inc.
公开号:US05723618A1
公开(公告)日:1998-03-03
The invention relates to a novel process to prepare 1,4-dihydropyridines and in particular amlopidine and in novel intermediates obtained during the synthesis of the 1,4-dihydropyridines which have potential activity as antihypertensive agents.
Three-component access to 2-pyrrolin-5-ones and their use in target-oriented and diversity-oriented synthesis
作者:Ángel Cores、Verónica Estévez、Mercedes Villacampa、J. Carlos Menéndez
DOI:10.1039/c6ra06317a
日期:——
The Hantzsch-type microwave-assisted, solvent-free sequential three-component reaction between primary amines, [small beta]-dicarbonyl compounds and [small alpha]-bromoesters in the presence of indium trichloride afforded 2-pyrrolin-5-ones, which are difficult to access by alternative methods....
Oxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania
作者:Esther Caballero、José Ignacio Manzano、Pilar Puebla、Santiago Castanys、Francisco Gamarro、Arturo San Feliciano
DOI:10.1016/j.bmcl.2012.07.100
日期:2012.10
Compounds belonging to three different classes of fused heterocyclic systems, structurally related to Calcium-channel blockers of the 1,4-dihydropyridine family, were evaluated in their ability to overcome leishmanial resistance to common drugs in a MDR Leishmania tropica strain. Compounds with the skeletal basis of oxazolo[3,2-a]pyridine displayed significant reversion of resistance to daunomycin and miltefosine, with reversion indexes up to 6.7-fold and 8.7-fold, respectively. Most interestingly, the enantiopure compound 20S attained to revert the resistance to both drugs and fairly more significantly than its enantiomer 20R. (C) 2012 Elsevier Ltd. All rights reserved.